Skip to main content

Table 1 Major published series of patients undergoing surgery for coexisting peritoneal carcinomatosis and liver metastases from colorectal cancer

From: A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature

Author Year n (peritoneal + liver/total) OS (peritoneal + liver/only peritoneal) Observations
Kianmanesh et al. 2007 37.2 % (16/43) 36 vs. 35.3 months No differences between groups
Only 70 % of patients having CC-0 or CC-1 surgery
Chua et al. 2009 29.1 % (16/55) 65 vs. 68 %, 2 years No differences between groups
Group of combined liver and peritoneal, lower PCI (8 vs. 12)
Varban et al. 2009 9.9 % (14/142) 23 vs. 15.8 months No differences between groups
43.3 vs. 36.8 %, 2 years Median number and size of liver metastasis: 1 (1–7) and 3 cm (0.4–12)
Elias et al. 2009 14.72 % (77/523) 21 vs. 27 %, 5 years Multicentric study
No differences between groups
Glehen et al. 2004 12.15 % (61/502) 16.8 vs. 20.4 months Liver metastasis as negative predictive factor for OS (p = 0.008)
Maggiori et al. 2013 37 vs. 60 40 vs. 66 %, 3 years Median OS 40 months for PCI <12 and 1 or 2 liver metastases
32 vs. 49 months